Espicom Business Intelligence Ltd, Feb 2012 TheOutlookforPharmaceuticalsinNorthEastAsia
Detailed analysis of four pharmaceutical markets that present immense potential for pharmaceutical manufacturers. China and Japan will be the
Global Industry Analysts, Inc., Oct 2011, Pages: 290
Geographic
Region - US, Canada, Japan, Europe, Asia - Pacific (excluding
Japan), Middle East & Africa, and Latin America Markets
Independently Analyzed with Annual Volume Sales in Million
Pounds for Years
Global Industry Analysts, Inc., Feb 2012, Pages: 178
Analysis for
Iodine in Animal Feed by Geographic Region - US, Canada,
Japan, Europe, Asia-Pacific (excluding Japan), Latin American
and Middle East Markets Independently Analyzed with
Espicom Business Intelligence Ltd, Feb 2012
Pakistan
TheOutlookforPharmaceuticalsin South EastAsia
Indonesia
Malaysia
Philippines
Singapore
South Korea
Taiwan
Thailand
Vietnam
TheOutlookforPharmaceuticalsinNorthEastAsia
China
Global Industry Analysts, Inc., April 2008, Pages: 215
Geographic Region – US, Canada, Japan, Europe,
Asia-Pacific (excluding Japan), Middle East and Latin America
Markets Independently Analyzed with Annual Sales Figures in
Metric Tons for
Global Industry Analysts, Inc., Jan 2011, Pages: 255
, Germany, China and Israel are some of the other significant potash producers inthe world. The agriculture-oriented economies of Asia and Latin America are identified as the fastest growing markets for
Decision Resources, Inc., Nov 2011
Will Big Pharma Find Success in Generics? Emerging markets are a key growth engine forthe pharmaceutical industry. Because of increasing pressure from patent expiries, reimbursement restrictions
Decision Resources, Inc., April 2011, Pages: 41
Opportunities in Emerging Markets - Newly Industrialized Asia (South Korea, Singapore, Taiwan, and Hong Kong SAR) What opportunities are available for pharmaceutical companies to pursue inthe newly
Decision Resources, Inc., Nov 2011
bolting on a biologics or vaccines company only a short-term stopgap for fixing this crisis?
- When Pfizer acquired Wyeth Pharmaceuticalsin 2009, the combined R&D spend of the two companies was about $11
Global Industry Analysts, Inc., April 2010, Pages: 1108
Patients intheUS, Canada,
Japan, Europe (Germany, France, UK, Italy, Spain and Rest
of Europe), China and Rest of World in Thousands for Years
2001 through 2010 (includes corresponding Graph/Chart) II-14
A
Global Industry Analysts, Inc., Oct 2011, Pages: 373
Radiopharmaceuticals by
Geographic Region - US, Canada, Japan, Europe, Asia-Pacific
(excluding Japan), and Rest of World Markets Independently
Analyzed with Annual Sales inUS$ Million for Years 2003
through 2008
Global Industry Analysts, Inc., Jan 2012, Pages: 239
abstracted and covered include United States, Canada, Europe, France, Germany, Italy, UK, Asia-Pacific, Latin America, and Middle East and Africa.
The report offers a compilation of recent mergers
Global Industry Analysts, Inc, Sep 2011, Pages: 363
: Prevalence of Diabetes Mellitus inThe Middle East
& North Africa (2010 & 2030): Breakdown by Country, Age
Group, and Gender (In ‘000 People & %) 29
6. DPP-IV
Global Industry Analysts, Inc., Oct 2011, Pages: 977
) 113
Table 51: World Recent Past, Current & Future Analysis for
Vitamins inPharmaceuticals by Geographic Region - US, Canada,
Japan, Europe, Asia-Pacific (excluding Japan), Latin America
and Rest
Global Industry Analysts, Inc., Sep 2010, Pages: 787
segments: Industrial, Municipal, Residential, and Commercial. The report provides separate comprehensive analytics fortheUS, Canada, Japan, Europe, Asia-Pacific, Latin America, and Middle East. Annual
Global Industry Analysts, Inc., Oct 2010, Pages: 278
Drive Nuclear Medicine Equipment Market inNorthAmerica 9
Future Growth Prospects for Medical Imaging Equipment Market 9
Global Industry Analysts, Inc., Aug 2010, Pages: 444
, Canada, Japan, Europe, Asia-Pacific
(excluding Japan), Middle East and Latin America Markets
Independently Analyzed with Annual Sales Figures inUS$
Million for Years 2001 through 2006 (includes
Industry Experts, July 2010, Pages: 216
REGIONAL MARKET PERSPECTIVE
Chart 28: The Projection of Largest Regions in terms of Market Growth for Human Embryonic Stem Cells by Geography – Asia-Pacific, Europe and NorthAmerica
Chart 29: Global Human
Global Industry Analysts, Inc., Jan 2012, Pages: 281
- US, Europe, Asia- Pacific and Rest of World with Annual Revenues inUS$ million for Years 2010 through 2015
Table 2: Global Biotechnology Market (2011&2015) Percentage Breakdown of Value Sales by
Global Industry Analysts, Inc., Jan 2012, Pages: 103
2015 forUS, Canada,
Europe, Asia-Pacific (including Japan),Latin America and
Rest of the World 7
2. ALUMINUM - NUMERO UNO 8
Brighter Outlookfor Aluminum Aerosol Cans 9
Aluminum Aerosol Demand in
